Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fuzhang Luo"'
Autor:
Dan Li, Zhihao Huo, Danyang Liu, Nirong Gong, Fen Zhang, Yaozhong Kong, Yunfang Zhang, Xiaoyan Su, Qingdong Xu, Jiexia Feng, Fuzhang Luo, Cheng Wang, Xianrui Dou, Guohui Sun, Difei Zhang, Xianhui Qin, Guangqing Zhang, Fuhua Lu, Jun Ai
Publikováno v:
The Journal of Clinical Hypertension, Vol 24, Iss 4, Pp 493-501 (2022)
Abstract Apparent treatment‐resistant hypertension (aTRH) is the most commonly used term to report resistant hypertension (RH) and is considered as a common problem in dialysis population. However, few reports have focused on peritoneal dialysis (P
Externí odkaz:
https://doaj.org/article/10443c5533814badafd75155ac8bc9d2
Publikováno v:
2022 International Conference on High Performance Big Data and Intelligent Systems (HDIS).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e651ad1fc35e7976c0b83c324d40e98
https://doi.org/10.1109/hdis56859.2022.9991685
https://doi.org/10.1109/hdis56859.2022.9991685
Autor:
Wei Zhang, Yanhong Tan, Jun Ai, Fuzhang Luo, Xiaoyan Su, Qimeng Wu, Lijuan Su, Jianyi Pan, Qingkun Zheng, Bin Li, Jiayi Chen, Qimei Luo, Jinzhong Chen, Xianrui Dou
Publikováno v:
Annals of translational medicine. 10(22)
Roxadustat and recombinant human erythropoietin (rhuEPO) have been approved for the treatment of renal anemia in patients undergoing dialysis. The comparison of risk of peritoneal dialysis (PD)-associated peritonitis between roxadustat and rhuEPO in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cf53df0207dcf0600bd44d516504f75
https://pubmed.ncbi.nlm.nih.gov/36544662
https://pubmed.ncbi.nlm.nih.gov/36544662